Cargando…
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
Anaplastic thyroid cancer (ATC) is a rare but aggressive thyroid cancer, responsible for about 50% of all thyroid cancer-related deaths. During the last two decades, the development of a multimodal personalized approach resulted in an increased survival. Here, we present an unusual case of a 54-year...
Autores principales: | Luongo, Cristina, Porcelli, Tommaso, Sessa, Francesca, De Stefano, Maria Angela, Scavuzzo, Francesco, Damiano, Vincenzo, Klain, Michele, Bellevicine, Claudio, Matano, Elide, Troncone, Giancarlo, Schlumberger, Martin, Salvatore, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700686/ https://www.ncbi.nlm.nih.gov/pubmed/34940089 http://dx.doi.org/10.3390/curroncol28060450 |
Ejemplares similares
-
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy
por: Luongo, C., et al.
Publicado: (2021) -
Paucicellular Fibroma of the Ascending Aorta
por: Pupovac, Stevan S., et al.
Publicado: (2021) -
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence
por: Angela De Stefano, Maria, et al.
Publicado: (2023) -
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma
por: Bedrose, Sara, et al.
Publicado: (2020) -
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
por: Boudin, Laurys, et al.
Publicado: (2022)